A Van Hoof
Impact in
-
- Lymphoma Diagnosis and Treatment
- Rheumatology top 10%
- Eosinophilic Disorders and Syndromes
Papers in
-
- Lymphoma Diagnosis and Treatment 3
-
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Peter Vandenberghe (2 shared papers)Iwona Włodarska (1 shared paper)Dominik Selleslag (1 shared paper)Florence E. Roufosse (1 shared paper)G. Verhoef (1 shared paper)Marie Maerevoet (1 shared paper)Jan Cools (1 shared paper)Peter Marynen (1 shared paper)
- Journals
- Annals of Oncology (1 paper)New England Journal of Medicine (1 paper)Leukemia (1 paper)Journal of Cardiovascular Pharmacology (1 paper)Molecular Cancer (1 paper)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
A Van Hoof
10 papers receiving 450 citations
Peers
Comparison fields: 5 of 43
- Pathology and Forensic Medicine 241
- Rheumatology 140
- Neurology 110
- Genetics 77
- Hematology 69
Countries citing papers authored by A Van Hoof
This map shows the geographic impact of A Van Hoof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Van Hoof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Van Hoof more than expected).
Fields of papers citing papers by A Van Hoof
This network shows the impact of papers produced by A Van Hoof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Van Hoof. The network helps show where A Van Hoof may publish in the future.
Co-authors
The 25 scholars most cited alongside A Van Hoof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 224 | |
| 2 | 2004 | 141 | |
| 3 | 1977 | 23 | |
| 4 | Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie. | 1997 | 20 |
| 5 | 1981 | 19 | |
| 6 | 1987 | 14 | |
| 7 | 2015 | 14 | |
| 8 | 1997 | 9 | |
| 9 | Cerebral venous thrombosis in paroxysmal nocturnal haemoglobinuria. | 1987 | 8 |
| 10 | Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884 | 2001 | 6 |
About A Van Hoof
A Van Hoof is a scholar working on Pathology and Forensic Medicine, Hematology, Pulmonary and Respiratory Medicine, Oncology and Hepatology, having authored 10 papers that have together received 478 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Mast cells and histamine (1 paper), Peripheral Artery Disease Management (1 paper), Liver Disease and Transplantation (1 paper), Muscle and Compartmental Disorders (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (241 citations), Rheumatology (140 citations), Neurology (110 citations), Genetics (77 citations) and Hematology (69 citations). A Van Hoof has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Peter Vandenberghe, Iwona Włodarska, Dominik Selleslag, Florence E. Roufosse, G. Verhoef, Marie Maerevoet, Jan Cools, Peter Marynen, Lucienne Michaux and M. A. Boogaerts. Their work appears in journals such as Annals of Oncology, New England Journal of Medicine, Leukemia, Journal of Cardiovascular Pharmacology and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.